Series: Meet The Digipharm Team Clinicians
Dr. Hasham Al-Meshhedani — Patient Engagement at Digipharm
Dr.Hasham Al- Al-Meshhedani is an Anesthetics & Critical Care Doctor with a background in Physiology and Pharmacology. He is diversely experienced in multiple medical specialties including Oncology, Cardiology, Respiratory Medicine, Emergency Medicine, General Surgery and Endocrinology. Involved in medical education and the use of technology to advance “Point of Care Learning” in the workplace. His current projects include research into advancing healthcare efficiency through innovative technologies.
How long have you been a clinician, and what is your specialty?
I have been a qualified doctor for… 9 years!….Gosh! How time flies!
Since qualifying, I have been through a number of specialties within medicine. This includes general internal medicine, emergency medicine and oncology to name just a few. However, I am currently a specialist registrar in Anaesthesia and Critical Care.
What is your role with Digipharm, and what drove you to join the team?
I have always been interested in digital health. Playing with expensive gadgets and new technology is what drove me to my chosen specialty! When I saw the emergence of blockchain technologies I immediately started to wonder about the possible benefits to the wider healthcare system.
My background prior to the medical profession was in Physiology and Pharmacology: the study of how drugs work and how they affect the body as well as the study surrounding drug development. This too has been something that highly interests me. So, Digipharm ticks all these boxes for me.
As a clinician I have a duty to be an advocate for my patients and I strive to practice evidence based medicine to improve patient outcomes according to the latest evidence and guidelines. I am also a passionate believer in value based care being the missing piece for modern healthcare systems. Especially in the NHS, as clinicians we have the responsibility to improve the outcomes of our patients while improving healthcare efficiency. With digipharm we can reduce the problem of access to expensive treatments because with value based pricing we can reduce the burden from drugs that are less effective and focus on more effective treatments depending on the outcomes that we want to achieve.
My role within Digipharm is to bring together patients and clinicians to improve access and engagement to shape the future of this platform to meet their needs across multiple disciplines.
How can innovative pricing models change the healthcare industry?
Its simple really- people and healthcare systems will pay the right price for the right medications. These drugs make a difference to patients outcomes. Pricing structures based on outcomes as opposed to volume will free up resources to drugs that make a difference in the lives of patients. It incentivises pharmaceutical companies to work hard to provide drugs that do the intended job and do it well.
Can you think of a time where value based pricing models would have changed a patients life, or made your job different/better?
How can innovative pricing models change the healthcare industry?
Its simple really- people and healthcare systems will pay the right price for the right medications. These drugs make a difference to patients outcomes. Pricing structures based on outcomes as opposed to volume will free up resources to drugs that make a difference in the lives of patients. It incentivises pharmaceutical companies to work hard to provide drugs that do the intended job and do it well.
Can you think of a time where value based pricing models would have changed a patients life, or made your job different/better?
In 2016 the NHS in the UK spent £16.8 Billion on medicines, this had gone up by 8% from the year before and 29% form 6 years before that! Its simply not sustainable. Value based pricing is a solution that all healthcare systems need, and have needed for quite some time. It will be for the benefit of all patients, collectively, and allow us to ensure that medicines are priced according to the outcomes that they help to produce. We can monitor these outcomes through the real world evidence database, Insights.
For more information about Digipharm’s solutions, visit our website and connect with us socially:
LinkedIn: https://www.linkedin.com/company/digipharm/
Bitcointalk Username: Nexjr14
Bitcointalk Link: https://bitcointalk.org/index.php?action=profile;u=1589980;sa=summary
Bitcointalk Username: Nexjr14
Bitcointalk Link: https://bitcointalk.org/index.php?action=profile;u=1589980;sa=summary
0 comments:
Speak up your mind
Tell us what you're thinking... !